2026年全球組織心臟瓣膜市場報告

近年來，組織心臟瓣膜市場持續擴張，預計將以2.6%的複合年成長率成長，從2025年的15.2億美元成長到2026年的15.6億美元。過去幾年成長要素包括心血管疾病的增加、機械瓣膜的局限性、外科瓣膜置換術的廣泛應用、醫院心臟護理基礎設施的完善以及人口老化。

預計未來幾年，組織瓣膜市場將穩定成長，到2030年達到17.2億美元，複合年成長率（CAGR）為2.5%。預測期內的成長要素包括經導管主動脈瓣置換術術（TAVR）的普及、微創心血管手術的興起、提高瓣膜耐久性的技術創新、醫療服務可及性的提高以及心臟病學專業化的不斷發展。預測期內的主要趨勢包括：人們對生物瓣膜的偏好日益增強、經導管瓣膜置換術數量的增加、組織保存技術的進步、長期抗凝血治療使用率的下降以及人口老齡化導致的瓣膜置換需求成長。

預計未來幾年，心血管疾病（CVD）盛行率的不斷上升將推動組織瓣膜市場的發展。心血管疾病，包括心肌梗塞、中風和高血壓，是全球主要死因之一。這一成長主要歸因於不健康的生活方式、人口老化以及不合理飲食、缺乏運動、吸煙、壓力和都市化等風險因素的增加，導致心臟相關疾病的發病率不斷上升。生物瓣膜在心血管疾病的治療中發揮關鍵作用，為需要瓣膜置換的患者提供了一種生物相容性好、經久耐用且低血栓形成性的解決方案。這有助於改善患者的長期心臟功能並減少併發症。例如，根據美國心臟衰竭協會（HFSA）2024年9月發布的報告，大約有670萬20歲及以上的美國人患有心臟衰竭（HF），預計到2030年這一數字將增至870萬，到2040年將增至1030萬，到2050年將增至1140萬。心血管疾病的這種成長趨勢正在推動對生物人工心臟瓣膜的需求。

組織源性心臟瓣膜市場的公司正致力於透過技術創新來改善患者的治療效果。例如，總部位於愛爾蘭的科技公司Medtronic）於2024年6月推出了新一代外科主動脈組織瓣膜－Avalus Ultra。該產品旨在提高植入過程中的操作性，並支持患者的長期管理。 Avalus Ultra基於Avalus瓣膜10年的臨床經驗開發而成，採用低輪廓設計，聚醚醚酮（PEEK）基座框架確保瓣膜的圓形穩定性，並擁有業界領先的有效瓣膜面積（EOA），從而改善血流。此外，該瓣膜還內建滲透性的線圈，以提高未來瓣中瓣手術的可見度，從而確保主動脈瓣狹窄患者的長期療效。

目錄

第1章執行摘要

第2章 市場特徵

• 市場定義和範圍
• 市場區隔
• 主要產品和服務概述
• 全球組織心臟瓣膜市場：吸引力評分及分析
• 成長潛力分析、競爭評估、策略契合度評估、風險狀況評估

第3章 市場供應鏈分析

• 供應鏈與生態系概述
• 主要原料、資源和供應商清單
• 主要經銷商和通路合作夥伴名單
• 主要最終用戶列表

第4章 全球市場趨勢與策略

• 關鍵技術和未來趨勢
  • 生物技術、基因組學和精準醫學
  • 人工智慧（AI）和自主人工智慧
  • 工業4.0和智慧製造
  • 數位化、雲端運算、巨量資料、網路安全
  • 永續性、氣候技術和循環經濟
• 主要趨勢
  • 生物瓣膜的偏好
  • 經導管瓣膜置換術增加
  • 組織保存技術的改進
  • 長期抗凝血治療使用減少
  • 人口老化導致瓣膜置換需求增加

第5章 終端用戶產業市場分析

• 醫院
• 心臟中心
• 門診手術中心
• 心臟研究所
• 大學附設心臟醫院

第6章 市場：宏觀經濟情景，包括利率、通貨膨脹、地緣政治、貿易戰和關稅的影響、關稅戰和貿易保護主義對供應鏈的影響，以及新冠疫情對市場的影響

第7章 全球策略分析架構、目前市場規模、市場對比及成長率分析

• 全球組織心臟瓣膜市場：PESTEL 分析（政治、社會、技術、環境、法律因素、促進因素和限制因素）
• 全球組織心臟瓣膜市場規模、比較及成長率分析
• 全球組織心臟瓣膜市場表現：規模與成長，2020-2025年
• 全球組織心臟瓣膜市場預測：規模與成長，2025-2030年，2035年預測

第8章 全球潛在市場總量（TAM）

第9章 市場細分

• 按類型
• 附支架和不含支架的生物瓣膜
• 依手術類型
• 外科主動脈瓣置換術（SAV​​R）、經導管主動脈瓣置換術（TAVR）
• 最終用戶
• 醫院、門診手術中心和其他最終用戶
• 按類型細分：附支架生物瓣膜
• 牛，豬瓣膜
• 按類型細分：無支架生物瓣膜
• 牛無支架瓣膜，均質瓣膜

第10章 區域與國家分析

• 全球組織心臟瓣膜市場：區域分析、預測與趨勢，2020-2025年、2025-2030年預測、2035年預測
• 全球組織心臟瓣膜市場：依國家、表現及預測分類，2020-2025年、2025-2030年預測、2035年預測

第11章 亞太市場

第12章：中國市場

第13章 印度市場

第14章 日本市場

第15章：澳洲市場

第16章 印尼市場

第17章 韓國市場

第18章 台灣市場

第19章 東南亞市場

第20章：西歐市場

第21章英國市場

第22章 德國市場

第23章：法國市場

第24章：義大利市場

第25章：西班牙市場

第26章 東歐市場

第27章：俄羅斯市場

第28章 北美市場

第29章：美國市場

第30章：加拿大市場

第31章 南美洲市場

第32章：巴西市場

第33章 中東市場

第34章：非洲市場

第35章 市場監理與投資環境

第36章：競爭格局與公司概況

• 組織心臟瓣膜市場：競爭格局與市場佔有率，2024 年
• 組織心臟瓣膜市場：公司估價矩陣
• 組織心臟瓣膜市場：公司概況
  • Abbott Laboratories
  • Medtronic PLC
  • Edwards Lifesciences Corporation
  • LivaNova PLC
  • Meril Life Sciences Pvt. Ltd.

第37章：其他領先和創新企業

• MicroPort Scientific Corporation, LifeNet Health Inc., TTK Healthcare Ltd., Braile Biomedica, Anteris Technologies Ltd., Labcor Laboratorios Ltd., CARDION sro, CryoLife Inc., Colibri Heart Valve LLC, Foldax Inc., Balance Medical Technologies Co. Ltd., MiCardia Corporation, St. Jude Medical Inc., Sorin Group, Hancock J & Co.

第38章 全球市場競爭基準分析與儀錶板

第39章 重大併購

第40章：高潛力市場國家、細分市場與策略

• 2030年組織心臟瓣膜市場：提供新機會的國家
• 2030年組織心臟瓣膜市場：充滿新機會的細分市場
• 2030年組織心臟瓣膜市場：成長策略
  • 基於市場趨勢的策略
  • 競爭對手策略

第41章附錄

Tissue heart valves are biological heart valves used in replacement surgeries, designed to function such as natural heart valves as an alternative to mechanical ones.

The primary types of tissue heart valves are stented and stentless valves. Stented tissue heart valves are bioprosthetic valves reinforced with a metal or polymer frame (stent) to provide structural support and simplify implantation during valve replacement procedures. These valves come in various types, including aortic, mitral, tricuspid, and pulmonary valves. They are utilized by multiple end-users, such as hospitals, ambulatory surgical centers, and other medical facilities.

Tariffs have influenced the tissue heart valves market by increasing costs of processed biological tissues, precision stents, and sterilization technologies. Stented tissue valve segments and aortic valve replacements are most impacted, especially in North America and Europe. While tariffs elevate device pricing, they also promote localized valve manufacturing, improved supply-chain control, and innovation in cost-efficient bioprosthetic valve designs.

The tissue heart valves market research report is one of a series of new reports from The Business Research Company that provides tissue heart valves market statistics, including tissue heart valves industry global market size, regional shares, competitors with a tissue heart valves market share, detailed tissue heart valves market segments, market trends and opportunities, and any further data you may need to thrive in the tissue heart valves industry. This tissue heart valves market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The tissue heart valves market size has grown steadily in recent years. It will grow from $1.52 billion in 2025 to $1.56 billion in 2026 at a compound annual growth rate (CAGR) of 2.6%. The growth in the historic period can be attributed to growth in cardiovascular diseases, limitations of mechanical valves, surgical valve replacement adoption, hospital cardiac infrastructure, aging demographics.

The tissue heart valves market size is expected to see steady growth in the next few years. It will grow to $1.72 billion in 2030 at a compound annual growth rate (CAGR) of 2.5%. The growth in the forecast period can be attributed to expansion of TAVR procedures, minimally invasive cardiac surgery growth, longer valve durability innovation, rising healthcare access, cardiology specialization growth. Major trends in the forecast period include preference for bioprosthetic valves, rising transcatheter valve procedures, improved tissue preservation techniques, reduced long-term anticoagulation use, aging population valve replacement demand.

The increasing prevalence of cardiovascular diseases (CVDs) is expected to drive the growth of the tissue heart valves market in the coming years. CVDs, which include conditions such as heart attacks, strokes, and hypertension, are among the leading causes of mortality worldwide. This rise is primarily driven by unhealthy lifestyles, aging populations, increased prevalence of risk factors, poor diets, physical inactivity, smoking, stress, and urbanization, all contributing to higher rates of heart-related disorders. Tissue heart valves play a crucial role in treating cardiovascular diseases by offering a biocompatible, durable, and less thrombogenic solution for patients requiring valve replacement, ultimately improving long-term heart function and reducing complications. For example, in September 2024, a report by the Heart Failure Society of America (HFSA) stated that approximately 6.7 million Americans aged 20 and older are living with heart failure (HF), with projections estimating this number to rise to 8.7 million by 2030, 10.3 million by 2040, and 11.4 million by 2050. This rising burden of CVDs is fueling the demand for tissue heart valves.

Companies operating in the tissue heart valves market are focusing on technological innovations to improve patient outcomes. For instance, in June 2024, Medtronic plc, an Ireland-based technology company, launched the Avalus Ultra valve, a next-generation surgical aortic tissue valve designed to enhance ease of use during implantation and support long-term patient management. This valve, built on a decade of clinical experience with the Avalus valve, features a low profile, a polyetheretherketone (PEEK) base frame for consistent circularity, and an industry-leading Effective Orifice Area (EOA) to improve blood flow. Additionally, it includes a radiopaque coil for better visibility in future valve-in-valve procedures, ensuring long-term durability for patients with aortic stenosis.

In February 2024, Foldax Inc., a US-based medical device company, partnered with Dolphin Life Science India LLP to manufacture the Tria polymer mitral surgical heart valve in India. This collaboration enables in-country production and distribution, making advanced heart valve solutions more accessible to patients. Dolphin Life Science India LLP is an India-based life sciences company specializing in heart valve manufacturing and distribution.

Major companies operating in the tissue heart valves market are Abbott Laboratories, Medtronic PLC, Edwards Lifesciences Corporation, LivaNova PLC, Meril Life Sciences Pvt. Ltd., MicroPort Scientific Corporation, LifeNet Health Inc., TTK Healthcare Ltd., Braile Biomedica, Anteris Technologies Ltd., Labcor Laboratorios Ltd., CARDION s.r.o., CryoLife Inc., Colibri Heart Valve LLC, Foldax Inc., Balance Medical Technologies Co. Ltd., MiCardia Corporation, St. Jude Medical Inc., Sorin Group, Hancock J & Co.

North America was the largest region in the tissue heart valves market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the tissue heart valves market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the tissue heart valves market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The tissue heart valves market consists of sales of porcine xenograft valves, bovine pericardial valves, and autograft valves. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Tissue Heart Valves Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses tissue heart valves market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on end user analysis.
• Benchmark performance against key competitors based on market share, innovation, and brand strength.
• Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for tissue heart valves ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The tissue heart valves market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
• The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
• The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
• The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
• The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
• The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

• Markets Covered:1) By Type: Stented Tissue Heart Valves; Stentless Tissue Heart Valves
• 2) By Procedure Type: Surgical Aortic Valve Replacement (SAVR); Transcatheter Aortic Valve Replacement (TAVR)
• 3) By End-User: Hospitals; Ambulatory Surgical Centers; Other End-Users
• Subsegments:
• 1) By Stented Tissue Heart Valves: Bovine Pericardial Valves; Porcine Valves
• 2) By Stentless Tissue Heart Valves: Bovine Pericardial Stentless Valves; Homograft Valves
• Companies Mentioned: Abbott Laboratories; Medtronic PLC; Edwards Lifesciences Corporation; LivaNova PLC; Meril Life Sciences Pvt. Ltd.; MicroPort Scientific Corporation; LifeNet Health Inc.; TTK Healthcare Ltd.; Braile Biomedica; Anteris Technologies Ltd.; Labcor Laboratorios Ltd.; CARDION s.r.o.; CryoLife Inc.; Colibri Heart Valve LLC; Foldax Inc.; Balance Medical Technologies Co. Ltd.; MiCardia Corporation; St. Jude Medical Inc.; Sorin Group; Hancock J & Co.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: Word, PDF or Interactive Report
• + Excel Dashboard
• Added Benefits
• Bi-Annual Data Update
• Customisation
• Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

• 1.1. Key Market Insights (2020-2035)
• 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
• 1.3. Major Factors Driving the Market
• 1.4. Top Three Trends Shaping the Market

2. Tissue Heart Valves Market Characteristics

• 2.1. Market Definition & Scope
• 2.2. Market Segmentations
• 2.3. Overview of Key Products and Services
• 2.4. Global Tissue Heart Valves Market Attractiveness Scoring And Analysis
  • 2.4.1. Overview of Market Attractiveness Framework
  • 2.4.2. Quantitative Scoring Methodology
  • 2.4.3. Factor-Wise Evaluation
• Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
• 2.4.4. Market Attractiveness Scoring and Interpretation
• 2.4.5. Strategic Implications and Recommendations

3. Tissue Heart Valves Market Supply Chain Analysis

• 3.1. Overview of the Supply Chain and Ecosystem
• 3.2. List Of Key Raw Materials, Resources & Suppliers
• 3.3. List Of Major Distributors and Channel Partners
• 3.4. List Of Major End Users

4. Global Tissue Heart Valves Market Trends And Strategies

• 4.1. Key Technologies & Future Trends
  • 4.1.1 Biotechnology, Genomics & Precision Medicine
  • 4.1.2 Artificial Intelligence & Autonomous Intelligence
  • 4.1.3 Industry 4.0 & Intelligent Manufacturing
  • 4.1.4 Digitalization, Cloud, Big Data & Cybersecurity
  • 4.1.5 Sustainability, Climate Tech & Circular Economy
• 4.2. Major Trends
  • 4.2.1 Preference For Bioprosthetic Valves
  • 4.2.2 Rising Transcatheter Valve Procedures
  • 4.2.3 Improved Tissue Preservation Techniques
  • 4.2.4 Reduced Long-Term Anticoagulation Use
  • 4.2.5 Aging Population Valve Replacement Demand

5. Tissue Heart Valves Market Analysis Of End Use Industries

• 5.1 Hospitals
• 5.2 Cardiac Specialty Centers
• 5.3 Ambulatory Surgical Centers
• 5.4 Heart Institutes
• 5.5 Academic Cardiology Hospitals

6. Tissue Heart Valves Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Tissue Heart Valves Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

• 7.1. Global Tissue Heart Valves PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 7.2. Global Tissue Heart Valves Market Size, Comparisons And Growth Rate Analysis
• 7.3. Global Tissue Heart Valves Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
• 7.4. Global Tissue Heart Valves Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Tissue Heart Valves Total Addressable Market (TAM) Analysis for the Market

• 8.1. Definition and Scope of Total Addressable Market (TAM)
• 8.2. Methodology and Assumptions
• 8.3. Global Total Addressable Market (TAM) Estimation
• 8.4. TAM vs. Current Market Size Analysis
• 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Tissue Heart Valves Market Segmentation

• 9.1. Global Tissue Heart Valves Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Stented Tissue Heart Valves, Stentless Tissue Heart Valves
• 9.2. Global Tissue Heart Valves Market, Segmentation By Procedure Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Surgical Aortic Valve Replacement (SAVR), Transcatheter Aortic Valve Replacement (TAVR)
• 9.3. Global Tissue Heart Valves Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Hospitals, Ambulatory Surgical Centers, Other End-Users
• 9.4. Global Tissue Heart Valves Market, Sub-Segmentation Of Stented Tissue Heart Valves, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Bovine Pericardial Valves, Porcine Valves
• 9.5. Global Tissue Heart Valves Market, Sub-Segmentation Of Stentless Tissue Heart Valves, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Bovine Pericardial Stentless Valves, Homograft Valves

10. Tissue Heart Valves Market Regional And Country Analysis

• 10.1. Global Tissue Heart Valves Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• 10.2. Global Tissue Heart Valves Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Tissue Heart Valves Market

• 11.1. Asia-Pacific Tissue Heart Valves Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 11.2. Asia-Pacific Tissue Heart Valves Market, Segmentation By Type, Segmentation By Procedure Type, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Tissue Heart Valves Market

• 12.1. China Tissue Heart Valves Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 12.2. China Tissue Heart Valves Market, Segmentation By Type, Segmentation By Procedure Type, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Tissue Heart Valves Market

• 13.1. India Tissue Heart Valves Market, Segmentation By Type, Segmentation By Procedure Type, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Tissue Heart Valves Market

• 14.1. Japan Tissue Heart Valves Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 14.2. Japan Tissue Heart Valves Market, Segmentation By Type, Segmentation By Procedure Type, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Tissue Heart Valves Market

• 15.1. Australia Tissue Heart Valves Market, Segmentation By Type, Segmentation By Procedure Type, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Tissue Heart Valves Market

• 16.1. Indonesia Tissue Heart Valves Market, Segmentation By Type, Segmentation By Procedure Type, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Tissue Heart Valves Market

• 17.1. South Korea Tissue Heart Valves Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 17.2. South Korea Tissue Heart Valves Market, Segmentation By Type, Segmentation By Procedure Type, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Tissue Heart Valves Market

• 18.1. Taiwan Tissue Heart Valves Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 18.2. Taiwan Tissue Heart Valves Market, Segmentation By Type, Segmentation By Procedure Type, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Tissue Heart Valves Market

• 19.1. South East Asia Tissue Heart Valves Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 19.2. South East Asia Tissue Heart Valves Market, Segmentation By Type, Segmentation By Procedure Type, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Tissue Heart Valves Market

• 20.1. Western Europe Tissue Heart Valves Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 20.2. Western Europe Tissue Heart Valves Market, Segmentation By Type, Segmentation By Procedure Type, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Tissue Heart Valves Market

• 21.1. UK Tissue Heart Valves Market, Segmentation By Type, Segmentation By Procedure Type, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Tissue Heart Valves Market

• 22.1. Germany Tissue Heart Valves Market, Segmentation By Type, Segmentation By Procedure Type, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Tissue Heart Valves Market

• 23.1. France Tissue Heart Valves Market, Segmentation By Type, Segmentation By Procedure Type, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Tissue Heart Valves Market

• 24.1. Italy Tissue Heart Valves Market, Segmentation By Type, Segmentation By Procedure Type, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Tissue Heart Valves Market

• 25.1. Spain Tissue Heart Valves Market, Segmentation By Type, Segmentation By Procedure Type, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Tissue Heart Valves Market

• 26.1. Eastern Europe Tissue Heart Valves Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 26.2. Eastern Europe Tissue Heart Valves Market, Segmentation By Type, Segmentation By Procedure Type, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Tissue Heart Valves Market

• 27.1. Russia Tissue Heart Valves Market, Segmentation By Type, Segmentation By Procedure Type, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Tissue Heart Valves Market

• 28.1. North America Tissue Heart Valves Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 28.2. North America Tissue Heart Valves Market, Segmentation By Type, Segmentation By Procedure Type, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Tissue Heart Valves Market

• 29.1. USA Tissue Heart Valves Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 29.2. USA Tissue Heart Valves Market, Segmentation By Type, Segmentation By Procedure Type, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Tissue Heart Valves Market

• 30.1. Canada Tissue Heart Valves Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 30.2. Canada Tissue Heart Valves Market, Segmentation By Type, Segmentation By Procedure Type, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Tissue Heart Valves Market

• 31.1. South America Tissue Heart Valves Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 31.2. South America Tissue Heart Valves Market, Segmentation By Type, Segmentation By Procedure Type, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Tissue Heart Valves Market

• 32.1. Brazil Tissue Heart Valves Market, Segmentation By Type, Segmentation By Procedure Type, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Tissue Heart Valves Market

• 33.1. Middle East Tissue Heart Valves Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 33.2. Middle East Tissue Heart Valves Market, Segmentation By Type, Segmentation By Procedure Type, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Tissue Heart Valves Market

• 34.1. Africa Tissue Heart Valves Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 34.2. Africa Tissue Heart Valves Market, Segmentation By Type, Segmentation By Procedure Type, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Tissue Heart Valves Market Regulatory and Investment Landscape

36. Tissue Heart Valves Market Competitive Landscape And Company Profiles

• 36.1. Tissue Heart Valves Market Competitive Landscape And Market Share 2024
  • 36.1.1. Top 10 Companies (Ranked by revenue/share)
• 36.2. Tissue Heart Valves Market - Company Scoring Matrix
  • 36.2.1. Market Revenues
  • 36.2.2. Product Innovation Score
  • 36.2.3. Brand Recognition
• 36.3. Tissue Heart Valves Market Company Profiles
  • 36.3.1. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.2. Medtronic PLC Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.3. Edwards Lifesciences Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.4. LivaNova PLC Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.5. Meril Life Sciences Pvt. Ltd. Overview, Products and Services, Strategy and Financial Analysis

37. Tissue Heart Valves Market Other Major And Innovative Companies

• MicroPort Scientific Corporation, LifeNet Health Inc., TTK Healthcare Ltd., Braile Biomedica, Anteris Technologies Ltd., Labcor Laboratorios Ltd., CARDION s.r.o., CryoLife Inc., Colibri Heart Valve LLC, Foldax Inc., Balance Medical Technologies Co. Ltd., MiCardia Corporation, St. Jude Medical Inc., Sorin Group, Hancock J & Co.

38. Global Tissue Heart Valves Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Tissue Heart Valves Market

40. Tissue Heart Valves Market High Potential Countries, Segments and Strategies

• 40.1 Tissue Heart Valves Market In 2030 - Countries Offering Most New Opportunities
• 40.2 Tissue Heart Valves Market In 2030 - Segments Offering Most New Opportunities
• 40.3 Tissue Heart Valves Market In 2030 - Growth Strategies
  • 40.3.1 Market Trend Based Strategies
  • 40.3.2 Competitor Strategies

41. Appendix

• 41.1. Abbreviations
• 41.2. Currencies
• 41.3. Historic And Forecast Inflation Rates
• 41.4. Research Inquiries
• 41.5. The Business Research Company
• 41.6. Copyright And Disclaimer